Back to results
US 2019/0240201 A1Published application
Ocular formulations for drug-delivery to the posterior segment of the eye
AssigneePanOptica, Inc.
InventorsDavid P. BINGAMAN, Paul G. CHANEY, Martin B. WAX
Life of this patent
Estimating the term…
Abstract
The present invention relates to topical formulations comprising a compound of the following formula: for treating ocular neovascularization. The Compound-I is present in a solution or a suspension in about 0.005% to about 5.0% w/v, such that the solution or suspension delivers the compound at the posterior segment of the eye for inhibiting VEGF in the retina and/or the choroid.
Claims14
A topical ocular formulation, the formulation comprising:
- a. an active agent of Formula II:
- b. or a pharmaceutically acceptable salt thereof, and
- c. and pharmaceutically acceptable excipients;
- wherein the active agent or the pharmaceutically acceptable salt is present in about 0.005% to about 5.0% w/v such that the formulation forms a solution or a suspension.
1 more element
Dependencies are inferred from the claim text.